V Srivatsa, Executive VP-Equity at UTI AMC, remains positive on large private banks despite near-term pressure on NIMs, citing attractive valuations and stable credit costs. He also sees value emerging in IT stocks, where growth remains at 3-5% despite AI…
Among the worst hit were Persistent Systems, Coforge, Mphasis and LTIMindtree, which declined between 3% and 5%. Heavyweights including Wipro, Tata Consultancy Services and Infosys were down 2% to 3%.
Even as HAL’s numbers were better compared to CNBC-TV18’s poll expectations, on a year-on-year basis, the numbers paint a subdued picture. HAL’s net profit was up 5.7% from last year. However, its revenue grew only by 1.8% from last year.…
MTAR Technologies said it has secured orders worth $238.76 million, or nearly ₹2,279 crore, from an international customer, though further details were not disclosed.
As many as 6.4 lakh retail shareholders or those with authorized share capital of up to ₹2 lakh, have a 3.07% stake in Adani Enterprises at the end of the March quarter.
Dipan Mehta, Director at Elixir Equities, believes sharp corrections in quality growth stocks can create buying opportunities, even after disappointing earnings. He remains positive on Kaynes Technology India despite weak quarterly numbers, citing a strong order book and semiconductor plans.…
Alembic Pharmaceuticals shares gained after USFDA granted a tentative ANDA nod for Darolutamide Tablets 300 mg, a prostate cancer drug, marking its 238th ANDA approval.
Interarch Building Solution’s profit after tax declined 5.2% to ₹36.6 crore from ₹38.6 crore last year. Meanwhile, its revenues were up 8.7% at ₹503.6 crore from ₹463 crore in the previous year.
JPMorgan said Cipla’s upcoming pipeline, including launches of gVentolin, gAdvair, gSymbicort and select peptide products, as key growth drivers.
Following earnings from Balaji Amines, shares of its peer companies, Indo Amines, Amines & Plasticizers and Alkyl Amines are also trading with gains between 10% to 13% on Thursday.